Proteomic study of skeletal muscle in obesity and type 2 diabetes: progress and potential. (3rd October 2018)

• Record Type: Journal Article
• Authors: Kruse, Rikke; Højlund, Kurt
• Is Part Of: Expert review of proteomics. Volume 15:Number 10(2018)
• Page Start: 817
• Page End: 828
• Publication Date: 2018-10-03
• Subjects: Skeletal muscle -- type 2 diabetes -- subcellular fractionation -- quantitative proteomics -- mitochondria; Proteins -- Biotechnology -- Periodicals; Proteomics -- Periodicals; 572.6
• DOI: 10.1080/14789450.2018.1528147
• Languages: English
• ISSNs: 1478-9450

Abstract

ABSTRACT: Introduction : Skeletal muscle is the major site of insulin-stimulated glucose uptake and imparts the beneficial effects of exercise, and hence is an important site of insulin resistance in obesity and type 2 diabetes (T2D). Despite extensive molecular biology-oriented research the molecular mechanisms underlying insulin resistance in skeletal muscle remain to be established. Areas covered : The proteomic capabilities have greatly improved over the last decades. This review summarizes the technical challenges in skeletal muscle proteomics studies as well as the results of quantitative proteomic studies of skeletal muscle in relation to obesity, T2D, and exercise. Expert commentary : Current available proteomic studies contribute to the view that insulin resistance in obesity and T2D is associated with increased glycolysis and reduced mitochondrial oxidative metabolism in skeletal muscle, and that the latter can be improved by exercise. Future proteomics studies should be designed to markedly intensify the identification of abnormalities in metabolic and signaling pathways in skeletal muscle of insulin-resistant individuals to increase the understanding of the pathogenesis of T2D, but more importantly to identify multiple novel targets of treatment of which at least some can be safely targeted by novel drugs to treat and prevent T2D and reduce risk of cardiovascular disease.